9.3 C
New York
Tuesday, October 4, 2022

Buy now

spot_img

Dr. Reddy’s Lab Inks Licensing Pact With Slayback Pharma



Dr Reddy’s Labs enters into pact with US-based Slayback Pharma to acquire rights of a medication to relieve redness of the eyes.



Source link

Related Articles

Stay Connected

0FansLike
3,513FollowersFollow
0SubscribersSubscribe
- Advertisement -spot_img

Latest Articles